HIMSS Media research uncovered the key areas where hospitals say AI and machine learning are already delivering value.
Artificial intelligence is so hyped that it might be tempting for top health executives to presume it’s just the domain of technologists, or so far off that they might be wiser waiting for others to move first.
Instead, it’s smart to consider where rival healthcare organizations are investing today. We surveyed 142 qualified professionals working in IT, business, informatics and clinical roles within hospitals, health insurers, and pharmaceutical companies.
The findings show that artificial intelligence and machine learning are already delivering value in specific areas. Respondents have big hopes for AI and ML in clinical settings for chronic conditions in particular. The 77 percent of survey-takers who say they’re using AI to support clinical decisions represent the most common use case being tested – but not the only one by far.
Let’s dig into some of our findings in the following charts.
AI and machine learning are already delivering value in specialty care including radiology, pathology and pharma, according to 63 percent of the research participants.
When it comes to patients, the technologies are also delivering value, 61 percent of respondents indicated, with telehealth and remote patient monitoring cited as two specific examples.